Literature DB >> 29507449

1,3,4-Oxadiazole and Heteroaromatic-Fused 1,2,4-Triazole Synthesis using Diverted Umpolung Amide Synthesis.

Kazuyuki Tokumaru1, Kalisankar Bera1, Jeffrey N Johnston1.   

Abstract

Umpolung Amide Synthesis (UmAS) has emerged as a superior alternative to conventional amide synthesis methods based on carbonyl electrophiles in a range of situations, particularly when epimerization-prone couplings are prescribed. In an unanticipated development during our most recent studies, it was discovered that diacyl hydrazide products from UmAS were not formed as intermediates when using an acyl hydrazide as the amine acceptor. This resulted in a new preparation of 1,3,4-oxadiazoles from α-bromonitroalkane donors. We hypothesized that a key tetrahedral intermediate in UmAS was diverted toward a more direct pathway to the heterocycle product rather than through formation of the diacyl hydrazide, a typical oxadiazole progenitor. In studies reported here, diversion to 1,2,4-triazole products is described, a behavior hypothesized to also result from an analogous tetrahedral intermediate, but one formed from heteroaromatic hydrazine acceptors.

Entities:  

Keywords:  diverted Umpolung Amide Synthesis; hydrazine; oxadiazole; pyrazine; pyridazine; pyrimidine; triazole; triazolopyridine

Year:  2017        PMID: 29507449      PMCID: PMC5833303          DOI: 10.1055/s-0036-1590802

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  19 in total

1.  Palladium-catalyzed coupling of aldehyde-derived hydrazones: practical synthesis of triazolopyridines and related heterocycles.

Authors:  Oliver R Thiel; Michal M Achmatowicz; Andreas Reichelt; Robert D Larsen
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

2.  Oxadiazole grafts in peptide macrocycles.

Authors:  John R Frost; Conor C G Scully; Andrei K Yudin
Journal:  Nat Chem       Date:  2016-10-24       Impact factor: 24.427

3.  Pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines as Selective, Brain Penetrant Phosphodiesterase 2 (PDE2) Inhibitors.

Authors:  Frederik J R Rombouts; Gary Tresadern; Peter Buijnsters; Xavier Langlois; Fulgencio Tovar; Thomas B Steinbrecher; Greet Vanhoof; Marijke Somers; José-Ignacio Andrés; Andrés A Trabanco
Journal:  ACS Med Chem Lett       Date:  2015-01-15       Impact factor: 4.345

4.  Discovery of competing anaerobic and aerobic pathways in umpolung amide synthesis allows for site-selective amide 18O-labeling.

Authors:  Jessica P Shackleford; Bo Shen; Jeffrey N Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

5.  Enantioselective Addition of Bromonitromethane to Aliphatic N-Boc Aldimines Using a Homogeneous Bifunctional Chiral Organocatalyst.

Authors:  Kenneth E Schwieter; Jeffrey N Johnston
Journal:  ACS Catal       Date:  2015       Impact factor: 13.084

6.  The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor.

Authors:  Yves Ducharme; Marc Blouin; Christine Brideau; Anne Châteauneuf; Yves Gareau; Erich L Grimm; Hélène Juteau; Sébastien Laliberté; Bruce MacKay; Frédéric Massé; Marc Ouellet; Myriam Salem; Angela Styhler; Richard W Friesen
Journal:  ACS Med Chem Lett       Date:  2010-04-13       Impact factor: 4.345

7.  One-Pot Synthesis of 2,5-Diaryl 1,3,4-Oxadiazoles via Di-tert-butyl Peroxide Promoted N-Acylation of Aryl Tetrazoles with Aldehydes.

Authors:  Liang Wang; Jing Cao; Qun Chen; Mingyang He
Journal:  J Org Chem       Date:  2015-04-17       Impact factor: 4.354

8.  Efficient addition reaction of bromonitromethane to aldehydes catalyzed by NaI: a new route to 1-bromo-1-nitroalkan-2-ols under very mild conditions.

Authors:  José M Concellón; Humberto Rodríguez-Solla; Carmen Concellón; Santiago García-Granda; M Rosario Díaz
Journal:  Org Lett       Date:  2006-12-21       Impact factor: 6.005

9.  Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Authors:  Mark C Dobish; Fernando Villalta; Michael R Waterman; Galina I Lepesheva; Jeffrey N Johnston
Journal:  Org Lett       Date:  2012-12-07       Impact factor: 6.005

10.  Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.

Authors:  Alessandro A Boezio; Katrina W Copeland; Karen Rex; Brian K Albrecht; David Bauer; Steven F Bellon; Christiane Boezio; Martin A Broome; Deborah Choquette; Angela Coxon; Isabelle Dussault; Satoko Hirai; Richard Lewis; Min-Hwa Jasmine Lin; Julia Lohman; Jingzhou Liu; Emily A Peterson; Michele Potashman; Roman Shimanovich; Yohannes Teffera; Douglas A Whittington; Karina R Vaida; Jean-Christophe Harmange
Journal:  J Med Chem       Date:  2016-02-11       Impact factor: 7.446

View more
  1 in total

1.  Enantioselective iodolactonization to prepare ε-lactone rings using hypervalent iodine.

Authors:  Jenna L Payne; Zihang Deng; Andrew L Flach; Jeffrey N Johnston
Journal:  Chem Sci       Date:  2022-06-08       Impact factor: 9.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.